natgillin/translations-raw huggingface dataset:
over for et eller flere hjælpestoffer, anført i afsnit 6, over for glutaraldehyd, formaldehyd, neomycin, streptomycin eller polymyxin B, da disse stoffer anvendes under fremstilllingen, efter tidligere indgivelse af Hexacima eller andre vacciner mod difteri, tetanus, pertussis, poliomyelitis, hepatitis B eller Hib.
to any of the excipients listed in section 6, to glutaraldehyde, formaldehyde, neomycin, streptomycin or polymyxin B, as these substances are used during the manufacturing process after previous administration of Hexacima or any other diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B or Hib containing vaccines.
over for et eller flere hjælpestoffer, anført i afsnit 6, over for glutaraldehyd, formaldehyd, neomycin, streptomycin eller polymyxin B, da disse stoffer anvendes under fremstilllingen, efter tidligere indgivelse af Hexacima eller andre vacciner mod difteri, tetanus, pertussis, poliomyelitis, hepatitis B eller Hib.
to any of the excipients listed in section 6, to glutaraldehyde, formaldehyde, neomycin, streptomycin or polymyxin B, as these substances are used during the manufacturing process. after previous administration of Hexacima or any other diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B or Hib containing vaccines.
over for et eller flere hjælpestoffer, anført i afsnit 6, over for glutaraldehyd, formaldehyd, neomycin, streptomycin eller polymyxin B, da disse stoffer anvendes under fremstilllingen, efter tidligere indgivelse af Hexyon eller andre vacciner mod difteri, tetanus, pertussis, poliomyelitis, hepatitis B eller Hib.
to any of the excipients listed in section 6, to glutaraldehyde, formaldehyde, neomycin, streptomycin or polymyxin B, as these substances are used during the manufacturing process after previous administration of Hexyon or any other diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B or Hib containing vaccines.
over for et eller flere hjælpestoffer, anført i afsnit 6, over for glutaraldehyd, formaldehyd, neomycin, streptomycin eller polymyxin B, da disse stoffer anvendes under fremstilllingen, efter tidligere indgivelse af Hexyon eller andre vacciner mod difteri, tetanus, pertussis, poliomyelitis, hepatitis B eller Hib.
to any of the excipients listed in section 6, to glutaraldehyde, formaldehyde, neomycin, streptomycin or polymyxin B, as these substances are used during the manufacturing process. after previous administration of Hexyon or any other diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B or Hib containing vaccines.
Over halvdelen (37 af 69) af de patienter, der fik Nucala, var i stand til at nedsætte deres daglige dosis af binyrebarkhormon med over 50 % til en dosis på 5 mg eller derunder, og 10 af dem var i stand til at komme helt ud af behandlingen med binyrebarkhormon, sammenholdt med omkring en tredjedel af dem, der fik placebo (22 af 66, hvoraf 5 var i stand til at holde op med binyrebarkhormon).
Over half (37 of 69) of the patients given Nucala were able to reduce their daily corticosteroid dose by more than 50% to a dose of 5 mg or less, and 10 of them were able to stop corticosteroids altogether, compared with about a third of those given placebo (22 of 66, of whom 5 were able to stop corticosteroids).
Over hele behandlingsperioden (i alt blev 3.430 patienter behandlet med Cosentyx i op til 52 uger for hovedparten af patienternes vedkommende) blev der rapporteret infektioner hos 47,5 % af de patienter, der blev behandlet med Cosentyx (0,9 pr. patientår med opfølgning).
Over the entire treatment period (a total of 3,430 patients treated with Cosentyx for up to 52 weeks for the majority of patients), infections were reported in 47.5% of patients treated with Cosentyx (0.9 per patient-year of follow-up).
Over lang tid (forsøg ACD2243g) øgedes antallet af hypersensivitetsrelaterede bivirkninger ikke (9,8% i de første 12 uger og minder end 6,65 i forsøgets resterende 12 ugers periode.
Over long term treatment, the frequency of hypersensitivity-related adverse events did not increase.
over normal
(6/18)
over normal
above normal
over normal
Baseline normal
over ‘DL 30’med guldfarvet blæk både på top og bund.
over ‘DL 30’ on both the cap and the body.
over-aktiv eller under-aktiv skjoldbruskkirtel eller hævelse af skjoldbruskkirtlen i halsen (struma)
over-active or under-active thyroid gland, or goitre (swelling of the thyroid gland in the neck)
Over-aktiv skjoldbruskkirtel (hypertyreose), hvor skjoldbruskkirtlen producerer for meget hormon
Over-active thyroid gland (hyperthyroidism) when the thyroid produces too much hormone
overaktiv hypofyse
overactive pituitary gland
overaktiv skjoldbruskkirtel
over-active thyroid
Overaktiv skjoldbruskkirtel
Overactive thyroid gland
overaktiv skjoldbruskkirtel, da timolol kan skjule tegn og symptomer på skjoldbruskkirtelsygdom
overactivity of the thyroid gland as timolol may mask signs and symptoms of thyroid disease
overaktiv skjoldbruskkirtel, der kan forårsage øget appetit, vægttab eller sveden
Overactive thyroid gland which can cause increased appetite, weight loss, or sweating
overaktiv skjoldbruskkirtel, der kan forårsage øget appetit, vægttab eller sveden
Overactive thyroid gland which can cause increased appetite, weight loss, or sweating;
overaktiv skjoldbruskkirtel, idet timolol kan skjule symptomer på skjoldbruskkirtelsygdom
overactivity of the thyroid gland as timolol may mask signs and symptoms of thyroid disease
Overam Lår Baller Bugen
Upper arm Thigh Buttock Abdomen
overarm
upper arm
Overarm
Upper arm Belly
Overdosering
0.0009
Overdosering
16.2 a
Overdosering
Biotransformation
Overdosering
Digoxin
Overdosering
Laboratory results
Overdosering
O verdose
Overdosering
Overdose:
Overdosering
Overdose‌‌
Overdosering
Renal insufficiency
Overdosering (symptomer, nødforanstaltninger, modgift) (om nødvendigt)
Overdose (symptoms, emergency procedures, antidotes), if necessary
Overdosering (symptomer, nødforanstaltninger, modgift) (om nødvendigt) Overdosis kan medføre døsighed hos heste.
Overdose (symptoms, emergency procedures, antidotes)(if necessary) An overdose can induce drowsiness in horses.
Overdosering (symptomer, nødforanstaltninger, modgift) om nødvendigt
Overdose (symptoms, emergency procedures, antidotes), if necessary
Overdosering (symptomer, nødforanstaltninger, modgift), om nødvendigt
Overdose (symptoms, emergency procedures, antidotes if necessary)
Overdosering (symptomer, nødforanstaltninger, modgift), om nødvendigt
Overdose (symptoms, emergency procedures, antidotes)
Overdosering (symptomer, nødforanstaltninger, modgift), om nødvendigt
Overdose (symptoms, emergency procedures, antidotes) (if necessary)
Overdosering (symptomer, nødforanstaltninger, modgift):
Overdose (symptoms, emergency procedures, antidotes)
Overdosering (symptomer, nødforanstaltninger, modgift):
Overdose (symptoms, emergency procedures, antidotes), if necessary
Overdosering (symptomer, nødhjælpsprocedurer, modgift)
Overdose (symptoms, emergency procedures, antidotes), if necessary
Overdosering af cinacalcet kan medføre hypokalcæmi.
Overdose of cinacalcet may lead to hypocalcaemia.
Overdosering af Visudyne kan forlænge tiden, hvor du er lysfølsom, og du kan blive nødt til at følge instruktionerne om beskyttelse i punkt 2 ud over de påkrævede 48 timer.
Overdose of Visudyne may prolong the time during which you are sensitive to light and you may need to follow the protection instructions given in section 2 for longer than 48 hours.
Overdosering efter topisk anvendelse er ikke sandsynlig og er ikke blevet rapporteret i de kliniske studier.
Overdose following topical administration is unlikely and has not been reported in clinical studies.
Overdosering er blevet rapporteret hos patienter i behandling med intravenøs topotecan (op til 10 gange den anbefalede dosis) og topotecan kapsler (op til 5 gange den anbefalede dosis).
Overdose has been reported in patients being treated with intravenous topotecan (up to 10 fold of the recommended dose) and topotecan capsules (up to 5 fold of the recommended dose).
Overdosering er blevet rapporteret hos patienter i behandling med topotecan kapsler (op til 5 gange den anbefalede dosis) og intravenøst topotecan (o til 10 gange den anbefalede dosis).
Overdoses have been reported in patients being treated with topotecan capsules (up to 5 fold of the recommended dose) and intravenous topotecan (up to 10 fold of the recommended dose) ..
Overdosering er blevet rapporteret hyppigere, når Ebilfumin blev givet til børn sammenlignet med voksne og unge.
Overdose has been reported to have occurred more frequently when oseltamivir was given to children than to adults and adolescents.
Overdosering er usandsynligt, da hver flaske med Dukoral kun indeholder én dosis.
Because each bottle of Dukoral contains only one dose, overdosage is unlikely.
Overdosering kan behandles ved at fremkalde opkastning eller ved gastrisk udskylning, og ved symptomatisk behandling.
Overdose may be treated by induction of emesis or by gastric lavage, and by symptomatic treatment.
Overdosering kan forbindes med signifikant hæmning af både MAO-A og MAO-B.
Overdose can be associated with significant inhibition of both MAO-A and MAO-B.
Overdosering kan medføre overhydrering og hyperviskositet, særlig hos patienter, der er udsat for risiko, herunder ældre patienter eller patienter med hjerte- eller nyreskader.
Overdose may lead to fluid overload and hyperviscosity, particularly in patients at risk, including elderly patients or patients with cardiac or renal impairment.
Overdosering kan medføre symptomer, der opstår ved en forstærkelse af prucaloprids kendte farmakodynamiske virkning, og som omfatter hovedpine, kvalme og diarré.
An overdose may result in symptoms resulting from an exaggeration of prucalopride’s known pharmacodynamic effects and include headache, nausea and diarrhoea.
Overdosering kan medføre væskeophobninger og hyperviskositet, især hos patienter i risikogruppen, herunder ældre patienter eller patienter med nedsat nyrefunktion.
Overdose may lead to fluid overload and hyperviscosity, particularly in patients at risk, including elderly patients or patients with renal impairment.
Overdosering kan også resultere i væskeansamlinger og hævelser i knæleddene.
Overdosage may also give rise to oedema and swelling in the knee joints.
Overdosering Kvæg:
Overdose Cattle:
Overdosering med 40 mg/kg (20 gange den anbefalede dosis) Clomicalm forårsagede krumrygget stilling, mindre rystelser, udspilet bug og nedsat aktivitet hos hunde.
Overdose with 40 mg/kg (20 times the recommended dose) of Clomicalm produced hunched posture, tremors, flushed abdomen and decreased activity in dogs.
Overdosering med amlodipin kan resultere i udtalt perifer vasodilatation og risiko for refleks- takykardi.
Overdose with amlodipine may result in excessive peripheral vasodilatation and possibly reflex tachycardia.
Overdosering med Episalvan er usandsynlig: Ved gentagne behandlinger af patienter med sårstørrelse >300 cm2 kunne der ikke påvises betulin i plasma.
Overdosing with Episalvan is unlikely: in patients in which wound sizes >300 cm2 were repeatedly treated with Episalvan, no betulin plasma levels could be detected.
Overdosering med insulin kan medføre svær og til tider langvarig og livstruende hypoglykæmi.
Insulin overdose may lead to severe and sometimes long-term and life-threatening hypoglycaemia.
Overdosering med oxybutynin er blevet sat i forbindelse med antikolinergiske effekter, herunder CNS- excitation, rødmen, feber, dehydrering, hjertearytmier, opkastning og urinretention.
Overdose with oxybutynin has been associated with anticholinergic effects including CNS excitation, flushing, fever, dehydration, cardiac arrhythmia, vomiting, and urinary retention.
Overdosering med oxybutynin er blevet sat i forbindelse med antikolinergiske effekter, herunder excitation i centralnervesystemet (CNS), hedeture, feber, dehydrering, hjertearytmier, opkastning og urinretention.
Overdosage with oxybutynin has been associated with anticholinergic effects including central nervous system (CNS) excitation, flushing, fever, dehydration, cardiac arrhythmia, vomiting, and urinary retention.
Overdosering na toediening van clopidogrel kan tot verlengde bloedingstijden en vervolgens tot bloedingscomplicaties leiden.
Overdose following clopidogrel administration may lead to prolonged bleeding time and subsequent bleeding complications.
Overdosering op til 10 gange den højeste anbefalede dosis på 1 mg/kg af den aktuelle legemsvægt kan forårsage opkastning eller diarré eller forhøjet ALT/AST (alaninaminotransferase/aspartataminotransferase)-niveau.
Overdose up to 10 times the maximum authorised dose of 1 mg/kg current bodyweight may produce vomiting or diarrhoea or increased ALT/AST (alanine aminotransferate/aspartate aminotransferate) levels.
Overdosering skal behandles, om nødvendigt, med et jernkeleringsmiddel.
Overdose should be treated, if required with an iron chelating agent.
Overdosering: Der er rapporteret om symptomer såsom dysfori, hypomani, hypertensive kriser og serotoninsyndrom efter overdosering med Azilect i doser fra 3 mg til 100 mg.
Overdosage: Symptoms reported following overdose of Azilect in doses ranging from 3 mg to 100 mg included dysphoria, hypomania, hypertensive crisis and serotonin syndrome.
Overdosering: Der er rapporteret om symptomer såsom dysfori, hypomani, hypertensive kriser og serotoninsyndrom efter overdosering med Rasagilin ratiopharm i doser fra 3 mg til 100 mg.
Overdosage: Symptoms reported following overdose of Rasagiline ratiopharm in doses ranging from 3 mg to 100 mg included dysphoria, hypomania, hypertensive crisis and serotonin syndrome.
Overdosis (symptomer, nødforanstaltninger, modgift)
Overdose (symptoms, emergency procedures, antidotes):
Overdosis (symptomer, nødforanstaltninger, modgift), om nødvendigt:
Overdose (symptoms, emergency procedures, antidotes) if necessary:
Overdosis (symptomer, nødforanstaltninger, modgift):
Overdose (symptoms, emergency procedures, antidotes)
Overdosis (symptomer, nødprocedure, antidoter):
Overdose (symptoms, emergency procedures, antidotes):
Overdosis af ASA/clopidogrel-fastdosiskombinationen kan være associeret med øget blødning og efterfølgende blødningskomplikationer grundet den farmakologiske aktivitet af clopidogrel og ASA.
Overdose with ASA/ clopidogrel fixed dose combination may be associated with increased bleeding and subsequent bleeding complications due to the pharmacological activity of clopidogrel and ASA.
Overdosis kan medføre døsighed hos heste
An overdose can induce drowsiness in horses
Overdosis kan medføre døsighed hos heste
An overdose can induce drowsiness in horses.
Overdosis kan medføre væske-overload og hyperviskositet, især hos patienter i risikogruppen, herunder ældre patienter eller patienter med nedsat nyrefunktion.
Overdose may lead to fluid overload and hyper viscosity, particularly in patients at risk, including elderly patients or patients with renal impairment.
Overdosis med ASA/clopidogrel fastdosiskombination kan være associeret med øget blødning og efterfølgende blødningskomplikationer grundet den farmakologiske aktivitet af clopidogrel og ASA.
Overdose with ASA/ clopidogrel fixed dose combination may be associated with increased bleeding and subsequent bleeding complications due to the pharmacological activity of clopidogrel and ASA.
overdreven brug af alkohol eller afhængighed af kokain eller stimulanser
excessive use of alcohol or addiction to cocaine or stimulants
Overdreven dannelse af nyt væv i såret (sjælden).
Excessive growth of new tissue at the wound (rare)
Overdreven følelse af velvære
Exaggerated feeling of wellbeing
Overdreven koageltykkelse kan interferere negativt med produktets effektivitet og sårhelingsprocessen.
Excessive clot thickness may negatively interfere with the product’s efficacy and the wound healing process
Overdreven koageltykkelse kan interferere negativt på produktets effektivitet og sårhelingsprocessen.
Excessive clot thickness may negatively interfere with the product’s efficacy and the wound healing process.
Overdreven nedsættelse af blodtryk hos patienter med iskæmisk kardiomyopati eller iskæmisk hjerte- karsygdom kan, som ved andre antihypertensiva, medføre myokardieinfarkt eller slagtilfælde.
As with any antihypertensive medicinal product, excessive reduction of blood pressure in patients with ischaemic cardiomyopathy or ischaemic cardiovascular disease could result in a myocardial infarction or stroke.
Overdreven produktion af spyt
Excessive production of saliva
overdreven spilletrang;
excessive gambling,
Overdreven spisning (indtagelse af store mængder mad inden for et kort tidsrum) eller tvangsspisning (at man spiser mere mad end normalt og mere end den mængde, der skal til for at stille sulten)
Binge eating (eating large amounts of food in a short time period) or compulsive eating (eating more food than normal and more than is needed to satisfy your hunger)
Overdreven spisning (indtagelse af store mængder mad inden for et kort tidsrum) eller tvangsspisning (at man spiser mere mad end normalt og mere end den mængde, der skal til for at stille sulten)*
Binge eating (eating large amounts of food in a short time period) or compulsive eating (eating more food than normal and more than is needed to satisfy your hunger)
Overdreven sveden, kløe
Excessive sweating, itching Feeling swollen or bloated
overdreven svedtendens
excessive sweating
Overdreven svedtendens (herunder nattesved)
Excessive sweating (including night sweats)
Overdreven tab af kropsvæske (dehydrering)
Excessive loss of body water (dehydration)
Overdreven tørst (Polydipsi)
Excessive thirst (Polydipsia)
Overdreven tørst, hyppigere vandladning (symptomer på for højt blodsukker)
Excessive thirst, increased frequency of urination (symptoms of high level of glucose in the blood)
overdrevne bevægelser (hyperkinesis);
hyperkinesis (exaggerated movements);
overdrevne kropsbevægelser
excessive body movements
Overdrevne ukontrollerbare indkøbs- og forbrugsvaner
Uncontrollable excessive shopping or spending
overensstemmelse med de historiske data.
consistent with historical data
Overensstemmelses niveau
Compliance level
Overensstemmelsesraten var 83 %.
The agreement rate was 83%.
overfladeantigen (proteiner fra overfladen) af hepatitis B-virus,
surface antigen (proteins from the surface) of the hepatitis B virus;
Overfladeantigenerne bliver også ‘adsorberet’.
The surface antigens are also ‘adsorbed’.
Overfladeantigenerne fremstilles ved hjælp af en metode kaldet rekombinant dna-teknologi: De produceres af en gærart, der har fået indsat et gen (dna), som sætter den i stand til at producere proteinerne.
The surface antigens are produced by a method known as ‘recombinant DNA technology’: they are made by a yeast that has received a gene (DNA), which makes it able to produce the proteins.
Overfladeantigenet af HBV (HBsAg) er fremstillet v.h.a. dyrkning af gensplejsede gærceller (Saccharomyces cerevisiae), som bærer genet, der koder for det vigtigste overfladeantigen af HBV.
The surface antigen of the HBV (HBsAg) is produced by culture of genetically-engineered yeast cells (Saccharomyces cerevisiae) which carry the gene coding for the major surface antigen of the HBV.
Overfladisk (% TBSA)
Superficial (%TBSA)
Overfladisk basalcellekræft
Superficial basal cell carcinoma.
overfladisk punktformig keratitis, corneaerosion, brænden i øjet, øjenirritation, allergisk konjunktivitis, blepharitis, dårligere skarpsyn, astenopi, konjunktivalt ødem, fornemmelse af fremmedlegeme i øjet, tørre øjne, øjensmerter, fotofobi, tåreflåd, øjenudflåd, visuelle forstyrrelser/sløret syn, øget irispigmentering, mørke øjenvipper, øjenlågserytem, øjenlågspruritus
uperficial punctate keratitis, corneal erosion, ocular burning, ocular irritation, allergic conjunctivitis, blepharitis, worsening of visual acuity, asthenopia, conjunctival oedema, foreign body sensation, ocular dryness, eye pain, photophobia, tearing, eye discharge, visual disturbance/blurred vision, increased iris pigmentation, eyelash darkening, eyelid erythema, eyelid pruritus
Overfladisk pusdannelse forårsaget af Staphylococcus intermedius.
Superficial pyoderma caused by Staphylococcus intermedius.
Overfladisk pyoderma forårsaget af Staphylococcus intermedius.
Superficial pyoderma caused by Staphylococcus intermedius.
Overfladisk pyodermi
Superficial pyoderma
Overfladisk pyodermi forårsaget af Staphylococcus intermedius.
Superficial pyoderma caused by Staphylococcus intermedius.
Overfladisk svampeinfektion
Superficial fungal infections
Overfladisk tromboflebitis
Superficial thrombophlebitis
Overfladisk vejrtrækning Ansigtshævelse
Shallow breathing Face swelling Sweatiness Muscle tightness
Overfladiske hudbetændelser
Superficial pyoderma
Overføl- somheds reaktioner
Hyper- sensitivity reactions
Overfølsom- hed
Hyper-sensitivity disorder
Overfølsom- hedsreak- tioner
hypersensitivity reactions
Overfølsom- hedsvaskulitis
<1/1,000)
Overfølsom- hedsvaskulitis
Hypersen- sitivity vasculitis
Overfølsom- hed†, bronko- spasme †, angioødem†, anafylaktisk reaktion/shock
Hypersensiti vity†, bronchospas m†, angioedema
Overfølsom- hed†, bronko- spasme †, angioødem†, anafylaktisk reaktion/shock
Hypersensitivity†, bronchospasm†, angioedema† anaphylactic reaction/shock
Overfølsomh ed
Hypersensitivity
Overfølsomhed
Hypersensitivit y
Overfølsomhed
Hypersensitivity reactions
Overfølsomhed
hypersensitivity.
overfølsomhed
Hypersensitivity;
Overfølsomhed
Sodium content
overfølsomhed (allergisk reaktion)
allergic reaction (hypersensitivity)
Overfølsomhed (allergisk reaktion)
Hypersensitivity (allergic reaction)
overfølsomhed (allergiske reaktioner)
hypersensitivity (allergic reactions)
overfølsomhed (anafylaksilignende reaktion) f.eks. udslæt, nældefeber (urticaria), åndedrætsbesvær (bronkospasmer)
hypersensitivity (anaphylactoid reactions) e.g. rash, hives (urticaria), difficulty breathing (bronchospasm)
Overfølsomhed (f.eks. bronkial hyperreaktivitet)
Hypersensitivity (e.g. bronchial hyperreactivity)
Overfølsomhed (f.eks. hævelser i mund og hals, kløe, hududslæt).
Hypersensitivity (e.g. swelling in the mouth and throat, itching, rash)
Overfølsomhed (G3/4:
Hypersensitivity (G3/4: 1.2%)
Overfølsomhed (G3/4:
Hypersensitivity (G3/4: 5.3%)
Overfølsomhed (G3/4: 0,6 %)
Hypersensitivity (G3/4: 0.6 %)
Overfølsomhed (G3/4: 0,6 %)
Hypersensivity (G3/4: 0.6%)
Overfølsomhed (G3/4: 1,2 %)
Hypersensitivity (G3/4: 1.2%)
Overfølsomhed (G3/4: 1,2 %)
Hypersensitivity (G3/4: 2.5%)
Overfølsomhed (G3/4: 1,7 %)
Hypersensitivity (no severe)
Overfølsomhed (G3/4: 1,7%)
Hypersensitivity (G3/4: 1.7%)
Overfølsomhed (G3/4: 2,5 %)
Hypersensitivity (G3/4: 1.2%)
Overfølsomhed (G3/4: 2,5 %)
Hypersensitivity (G3/4: 2.5%)
Overfølsomhed (G3/4: 5,3 %
Hypersensitivity (G3/4: 5.3%)
Overfølsomhed (G3/4: 5,3 %)
Hypersensitivity (G3/4: 5.3%)
Overfølsomhed (G3/4:1,2 %)
Hypersensitivity (no severe)
Overfølsomhed (herunder anafylaktisk reaktion, angioødem og urticaria) er blevet rapporteret.
Hypersensitivity (incl. anaphylactic reaction, angioedema and urticaria) has been reported.
Overfølsomhed (ikke alvorlig)
Hypersensitivity
overfølsomhed (inklusive erythema nodosum)
hypersensitivity (including erythema nodosum)
Overfølsomhed (specielt tidligere Stevens-Johnsons syndrom, toksisk epidermal nekrolyse, erythema multiforme) over for det aktive stof, den primære aktive metabolit teriflunomid eller nogle af de øvrige indholdsstoffer i tabletterne anført i pkt.
Hypersensitivity (especially previous Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme) to the active substance, to the principal active metabolite teriflunomide or to any of the excipients listed in section 6.1.
Overfølsomhed (specielt tidligere Stevens-Johnsons syndrom, toksisk epidermal nekrolyse, erythema multiforme) over for det aktive stof, den primære aktive metabolit teriflunomid eller over for et eller flere af hjælpestofferne anført i pkt.
Hypersensitivity (especially previous Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme) to the active substance, to the principal active metabolite teriflunomide or to any of the excipients listed in section 6.1.
Overfølsomhed (såsom anafylaksi, angioødem, dyspnø, pruritus, udslæt og urticaria)
Hypersensitivity (such as anaphylaxis, angioedema, dyspnoea, pruritus, rash, and urticaria)